← Insider buys
RPRX

Royalty Pharma plc · Healthcare

EVP and CFO Terrance P. Coyne sold $1.7M of Royalty Pharma plc

Sold$1,681,512
$48.33Price
34,791Shares
−22%Stake

What RPRX did after the filing

Filed Apr 2Copier in Apr 6
The stock from Mon, Apr 6 open, $47.77
+9.0%
S&P 500, same days
+12.6%

Measured over 30 trading days, to the May 18 close.

Traded Wed, Apr 1. Filed Thu, Apr 2, 5:58 PM ET, after the close. Returns use the Apr 6 open and the May 18 close. Not investment advice.